Netherlands· NL-62f3a7b8bca6
Zopranol HCTZ 30 mg/12,5 mg filmomhulde tabletten
A zofenopril und diuretika product containing hydrochloorthiazide + zofenopril calcium, registered in Netherlands by Menarini International Operations Luxembourg S.A.. The same ATC class is registered in 5 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Zofenopril und diuretika is registered in 5 of 19 countries.
Countries holding a registration under ATC C09BA15 (zofenopril und diuretika), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 3 of them publish a price we can compare per daily dose
Zofenopril und diuretika · ATC C09BA15
5 / 19 countries
- Finlandprice
- Ireland
- Italyprice
- Netherlands
- Polandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- HYDROCHLOORTHIAZIDE + ZOFENOPRIL CALCIUM
- Manufacturer
- Menarini International Operations Luxembourg S.A.
- Country
- Netherlands (NL)
- ATC code
- C09BA15
- ATC class
- Zofenopril und Diuretika
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id30936
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
40 interactions on record for zofenopril und diuretika.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Zofenopril und diuretika · interactions on record
40 records
40 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under C09BA15
Zofenopril und diuretika, as other registers publish it.
- FinlandBifril CompMenarini International Operations Luxembourg S.A.
- ItalyBIFRIZIDEISTITUTO LUSO FARMACO D'ITALIA S.P.A.
- ItalyINTERPRILS.F. GROUP S.R.L.
- ItalyZANTIPRIDEF.I.R.M.A. S.P.A.
- FinlandZofenil CompMenarini International Operations Luxembourg S.A.
- PolandZofenil PlusMenarini International Operations Luxembourg S.A.
- IrelandZofenil Plus 30 mg/12.5 mg film-coated tabletsMenarini International Operations Luxembourg S.A.
- ItalyZOFENOPRIL E IDROCLOROTIAZIDE DOC GENERICIDOC GENERICI S.R.L.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cdb6d722-f9a6-49ef-8674-8d5f0754b17f GET /v1/drugs/cdb6d722-f9a6-49ef-8674-8d5f0754b17f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmomhulde tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h30936_smpc.pdf",
"strength": null,
"atc_label": "Zofenopril And Diuretics",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg30936",
"excipients": [
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"HYPROMELLOSE (E 464)",
"IJZEROXIDE ROOD (E 172)",
"LACTOSE 1-WATER",
"MACROGOL",
"MAGNESIUMSTEARAAT (E 470b)",
"MAÏSZETMEEL",
"SILICIUMDIOXIDE (E 551)",
"TITAANDIOXIDE (E 171)"
],
"substances": [
"HYDROCHLOORTHIAZIDE",
"ZOFENOPRIL CALCIUM"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h30936.pdf",
"authorised_at": "2005/04/07",
"procedure_number": "NL/H/4680/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "30936",
"additional_monitoring": "N"
}See everything about zofenopril und diuretika.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.